<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00720720</url>
  </required_header>
  <id_info>
    <org_study_id>2006-03</org_study_id>
    <nct_id>NCT00720720</nct_id>
  </id_info>
  <brief_title>Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque</brief_title>
  <acronym>PHYTOPLAQUES</acronym>
  <official_title>Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>French Cardiology Society</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation Coeur et Artères</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>French Cardiology Society</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this exploratory study is to analyse in humans any qualitative changes of&#xD;
      carotid artery atherosclerotic plaque under the influence of plant sterols consumption.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment and organizational difficulties&#xD;
  </why_stopped>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effect of Phytosterols Enriched Products Consumption on Carotid Artery Artherosclerotic Plaque</measure>
    <time_frame>8 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hypercholesterolemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>plant sterol enriched margarine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo margarine</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>plant sterol enriched margarine</intervention_name>
    <description>Each group will have to consume 20 grams of margarines (either placebo or enriched in plant sterols) in one or two catches per day, for 8 weeks.</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo margarine</intervention_name>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient, men and women, aged between 40 to 75 ans (limits included) willing to&#xD;
             participate to the study and have signed informed consent for its participation in the&#xD;
             study&#xD;
&#xD;
          -  Displaying a non serious chirurgical indication of clinical asymptomatic carotid&#xD;
             stenosis defined by:&#xD;
&#xD;
               -  atherosclerotic stenosis of 60 to 75% on one on the two carotid junction&#xD;
                  (external carotid excluded) according to criteria from NASCET&#xD;
&#xD;
               -  without constituted or transitory recent cerebral vascular accident. The&#xD;
                  discovery of an ischaemic after-effect on a systematic scanner is not a criterion&#xD;
                  of exclusion&#xD;
&#xD;
          -  Subject with normal body weight or in over weight (Body Mass Index ranged between 19&#xD;
             and 30 kg/m2, [limits included])&#xD;
&#xD;
          -  Subject willing to follow dietary recommendations advised during hypercholesterolemia&#xD;
             (according to AFSSAPS' recommendations)&#xD;
&#xD;
          -  Subject with social insurance or equivalent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject who, according to AFSSAPS' recommendations, should received a&#xD;
             hypocholesterolemic therapy before the end of the study.&#xD;
&#xD;
          -  Subject with a history of diabetes&#xD;
&#xD;
          -  Subject with cardiac disease such as unstable angina, myocardial infarction, coronary&#xD;
             angioplasty, coronary artery bypass graft surgery, or moderate or severe congestive&#xD;
             heart failure within the last 6 months.&#xD;
&#xD;
          -  Subject with plasma triglyceride levels higher than 2,5 g/l [limit included],&#xD;
&#xD;
          -  Subject taking any drugs known to affect the evaluation of studied parameters&#xD;
&#xD;
          -  Subject with severe or acute disease that could affect the results of the study or&#xD;
             subject safety&#xD;
&#xD;
          -  Subject with regular consumption of phytosterol enriched foods products during the&#xD;
             study.&#xD;
&#xD;
          -  Subject with any other medical condition or laboratory abnormality prior to&#xD;
             recruitment that in the opinion of the principal investigator could affect subject&#xD;
             safety or render unlikely trial to be conducted to the end.&#xD;
&#xD;
          -  For women: pregnancy or breast feeding or subject likely to be pregnant during the&#xD;
             study.&#xD;
&#xD;
          -  For women: subject likely to modify their hormonal therapy during the study&#xD;
&#xD;
          -  Subject in exclusion period after its participation in an other clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric BRUCKERT, PU PH</last_name>
    <role>Principal Investigator</role>
    <affiliation>APHP</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hôpital cardio-vasculaire et pneumologique Louis Pradel</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Pitié-Salpêtrière, Endocrinology and Metabolism Department</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2008</verification_date>
  <study_first_submitted>July 21, 2008</study_first_submitted>
  <study_first_submitted_qc>July 22, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2008</study_first_posted>
  <last_update_submitted>April 2, 2010</last_update_submitted>
  <last_update_submitted_qc>April 2, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 5, 2010</last_update_posted>
  <responsible_party>
    <name_title>Anissa Bouzamondo, MD</name_title>
    <organization>French Society of Cardiology</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercholesterolemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

